Mechanistic aspects of green tea as a cancer preventive: Effect of components on human stomach cancer cell lines

被引:127
作者
Okabe, S
Ochiai, Y
Aida, M
Park, K
Kim, SJ
Nomura, T
Suganuma, M
Fujiki, H [1 ]
机构
[1] Saitama Canc Ctr, Res Inst, Ina, Saitama 3620806, Japan
[2] Toho Univ, Fac Pharmaceut Sci, Chiba 2740072, Japan
[3] Natl Canc Inst, Lab Cell Regulat & Carcinogenesis, Bethesda, MD USA
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1999年 / 90卷 / 07期
关键词
stomach cancer; apoptosis; TNF-alpha; AP-1; NF-kappa B;
D O I
10.1111/j.1349-7006.1999.tb00808.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is now well accepted that (-)-epigallocatechin gallate (EGCG) inhibits carcinogenesis in the digestive tract in rodents, To understand the mechanisms of anticarcinogenesis, we first studied growth inhibition by EGCG in human stomach cancer cell lines established at Seoul National University (SNU cell lines). Inhibition by EGCG of [H-3]thymidine incorporation into eight SNU cell lines was examined, in relation to transforming growth factor-beta (TGF-beta) responsiveness. Various tea polyphenols derived from green tea and black tea induced growth inhibition and apoptosis of human stomach cancer cell line KATO III, and inhibition of tumor necrosis factor-alpha (TNF-alpha) release from the cells, in the order of (-)-epicatechin gallate (ECG), EGCG, (-)-epigallocatechin (EGC), teaflavins (TF) and (-)-epicatechin (EC), In addition, me demonstrated that EGCG inhibited TNF-alpha gene expression in KATO III cells, as well as okadaic acid-induced AP-1 and NF-kappa B activation. The inhibitory potencies of EGCG for AP-1 and NF-kappa B binding to DNA were different between KATO III cells and mouse fibroblast cell line BALB/3T3. Thus, EGCG and other tea polyphenols may interact with various transcription factors, in addition to AP-1 and NF-kappa B, in nuclei of various cells, resulting in inhibition of TNF-alpha gene expression and TNF-alpha release.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 24 条
  • [11] Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B
    Natarajan, K
    Singh, S
    Burke, TR
    Grunberger, D
    Aggarwal, BB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (17) : 9090 - 9095
  • [12] INTERACTION OF NUCLEAR PROTEINS WITH AN AP-1 CRE-LIKE PROMOTER SEQUENCE IN THE HUMAN TNF-ALPHA GENE
    NEWELL, CL
    DEISSEROTH, AB
    LOPEZBERESTEIN, G
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1994, 56 (01) : 27 - 35
  • [13] DELETIONS OF THE CYCLIN-DEPENDENT KINASE-4 INHIBITOR GENE IN MULTIPLE HUMAN CANCERS
    NOBORI, T
    MIURA, K
    WU, DJ
    LOIS, A
    TAKABAYASHI, K
    CARSON, DA
    [J]. NATURE, 1994, 368 (6473) : 753 - 756
  • [14] Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols
    Okabe, S
    Suganuma, M
    Hayashi, M
    Sueoka, E
    Komori, A
    Fujiki, H
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (07): : 639 - 643
  • [15] GENETIC CHANGES IN THE TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) TYPE-II RECEPTOR GENE IN HUMAN GASTRIC-CANCER CELLS - CORRELATION WITH SENSITIVITY TO GROWTH-INHIBITION BY TGF-BETA
    PARK, KC
    KIM, SJ
    BANG, YJ
    PARK, JG
    KIM, NK
    ROBERTS, AB
    SPORN, MB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) : 8772 - 8776
  • [16] ACTIVATION OF TRANSCRIPTION FACTOR NF-KAPPA-B IS SUPPRESSED BY CURCUMIN (DIFERULOLYLMETHANE)
    SINGH, S
    AGGARWAL, BB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (42) : 24995 - 25000
  • [17] Spriggs D. R., 1992, TUMOR NECROSIS FACTO, P3
  • [18] Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression
    Sueoka, N
    Sueoka, E
    Okabe, S
    Fujiki, H
    [J]. CARCINOGENESIS, 1996, 17 (11) : 2337 - 2341
  • [19] TAUTOMYCIN - AN INHIBITOR OF PROTEIN PHOSPHATASE-1 AND PHOSPHSTASE-2A BUT NOT A TUMOR PROMOTER ON MOUSE SKIN AND IN RAT GLANDULAR STOMACH
    SUGANUMA, M
    OKABE, S
    SUEOKA, E
    NISHIWAKI, R
    KOMORI, A
    UDA, N
    ISONO, K
    FUJIKI, H
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (9-10) : 621 - 627
  • [20] Suganuma M, 1996, CANCER RES, V56, P3711